Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 32,314 | 78,123 | 19,712 | 25,544 | 90,732 |
| Gross Profit | 32,314 | 78,123 | 19,712 | 25,544 | 90,732 |
| Operating Expenses | 283,466 | 247,304 | 245,662 | 218,690 | 225,572 |
| Operating Income | -251,152 | -169,181 | -225,950 | -193,146 | -134,840 |
| Interest Expense | 0 | 0 | 0 | 0 | -16,259 |
| Other Income | 14,059 | 15,962 | 5,518 | 644 | 2,605 |
| Pre-tax Income | -237,093 | -153,219 | -220,432 | -192,502 | -115,976 |
| Net Income Continuous | -237,093 | -153,219 | -220,432 | -192,502 | -115,976 |
| Net Income | $-237,093 | $-153,219 | $-220,432 | $-192,502 | $-115,976 |
| EPS Basic Total Ops | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
| EPS Basic Continuous Ops | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
| EPS Diluted Total Ops | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
| EPS Diluted Continuous Ops | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
| EPS Diluted Before Non-Recurring Items | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 |
| EBITDA(a) | $-251,134 | $-167,940 | $-220,337 | $-186,436 | $-130,881 |